Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-23-012621)

Filing Details

Accession Number:: 0001415889-23-012621
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-08-24 18:05:07
Reporting Period:: 2023-08-22

Accepted Time:: 2023-08-24 18:05:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1583107	Theravance Biopharma Inc.	TBPH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1898490	Rhonda Farnum	C/O Theravance Biopharma Us, Inc. 901 Gateway Blvd South San Francisco CA 94080	Svp, Comm & Medical Affairs	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2023-08-22	1,807	$9.47	340,566	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023.